Requiring, beginning on January 1, 2023, the Maryland Medical Assistance Program to provide gender-affirming treatment in a nondiscriminatory manner; requiring that the gender-affirming treatment be assessed according to nondiscriminatory criteria that are consistent with current clinical standards; prohibiting the issuance of an adverse benefit determination related to gender-affirming treatment unless a certain experienced health care provider has reviewed and confirmed the appropriateness of the determination; etc.

Statutes affected:
Text - First - Maryland Medical Assistance Program - Gender-Affirming Treatment (Trans Health Equity Act of 2022): 15-103 Health General, 15-150 Health General, 2-024 Health General
Text - Third - Maryland Medical Assistance Program - Gender-Affirming Treatment (Trans Health Equity Act of 2022): 15-103 Health General, 15-150 Health General, 2-023 Health General, 2-024 Health General